Analgesics in Singapore

Analgesics in Singapore

When Singapore entered into Phase Three of the country’s safe-reopening at the start of 2021, public sentiment with regards to the pandemic somewhat eased as the situation appeared to be improving. This is likely to have supported the trend of patients who were suffering from mild symptoms, even if those symptoms were linked to COVID-19, delaying visits to medical clinics and instead preferring to monitor conditions at home first. This behaviour was typical amongst many local consumers prior to...

Euromonitor International's Analgesics in Singapore report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2016-2020, allowing you to identify the sectors driving growth. Forecasts to 2025 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.


Analgesics in Singapore
Euromonitor International
October 2021
List Of Contents And Tables
ANALGESICS IN SINGAPORE
KEY DATA FINDINGS
2021 DEVELOPMENTS
Increasing trend for self-medication using systemic analgesics to treat COVID-19 symptoms
Topical analgesics/anaesthetic experiences milder decline due to partial easing of restrictions and return to sports
Stress and anxiety amidst COVID-19 uncertainty could boost demand for analgesics
PROSPECTS AND OPPORTUNITIES
Rise in alternative solutions to pain relief could pose longer-term threat to category
Prolonged travel restrictions hinder performance for herbal/traditional topical analgesics
Increased awareness of side effects could reduce consumption of systemic analgesics
CATEGORY DATA
Table 1 Sales of Analgesics by Category: Value 2016-2021
Table 2 Sales of Analgesics by Category: % Value Growth 2016-2021
Table 3 NBO Company Shares of Analgesics: % Value 2017-2021
Table 4 LBN Brand Shares of Analgesics: % Value 2018-2021
Table 5 Forecast Sales of Analgesics by Category: Value 2021-2026
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2021-2026
CONSUMER HEALTH IN SINGAPORE
EXECUTIVE SUMMARY
Consumer health in 2021: The big picture
2021 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2016-2021
Table 8 Life Expectancy at Birth 2016-2021
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2016-2021
Table 10 Sales of Consumer Health by Category: % Value Growth 2016-2021
Table 11 NBO Company Shares of Consumer Health: % Value 2017-2021
Table 12 LBN Brand Shares of Consumer Health: % Value 2018-2021
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2016-2021
Table 14 Distribution of Consumer Health by Format: % Value 2016-2021
Table 15 Distribution of Consumer Health by Format and Category: % Value 2021
Table 16 Forecast Sales of Consumer Health by Category: Value 2021-2026
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2021-2026
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
Summary 1 OTC: Switches 2020-2021
DISCLAIMER
DEFINITIONS
SOURCES
Summary 2 Research Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook